Diamyd Medical AB (publ) Working Capital to Net Assets Ratio
Diamyd Medical AB (publ) working capital to net assets ratio. Diamyd Medical AB (publ) (DMYD-B) has a Working Capital to Net Assets ratio of 127.0% as of May 2026. Working capital of Skr329.46 Million (current assets of Skr352.18 Million minus current liabilities of Skr22.72 Million) is measured against net assets of Skr259.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Diamyd Medical AB (publ)'s equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Diamyd Medical AB (publ) (2010–2025)
Working capital to net assets ratio of Diamyd Medical AB (publ) from 2010 to 2025. This chart shows how Diamyd Medical AB (publ)'s Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of May 2026, the ratio stands at 127.0%, reflecting working capital of Skr329.46 Million against net assets of Skr259.39 Million SEK. See DMYD-B defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Diamyd Medical AB (publ) Working Capital to Net Assets Ratio by Year (2010–2025)
Diamyd Medical AB (publ) working capital to net assets ratio by year from 2010 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Diamyd Medical AB (publ) from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Diamyd Medical AB (publ) (DMYD-B) total assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 94.6% | Skr264.92 Million | Skr280.00 Million | Skr292.40 Million | Skr27.48 Million | ▲ +13.0 pp |
| 2024 | 81.6% | Skr119.12 Million | Skr145.92 Million | Skr159.14 Million | Skr40.02 Million | ▲ +10.2 pp |
| 2023 | 71.4% | Skr120.95 Million | Skr169.40 Million | Skr140.81 Million | Skr19.85 Million | ▲ +0.7 pp |
| 2022 | 70.7% | Skr151.64 Million | Skr214.38 Million | Skr173.01 Million | Skr21.37 Million | ▼ -9.4 pp |
| 2021 | 80.1% | Skr151.57 Million | Skr189.26 Million | Skr162.97 Million | Skr11.40 Million | ▲ +3.0 pp |
| 2020 | 77.1% | Skr55.90 Million | Skr72.49 Million | Skr72.39 Million | Skr16.50 Million | ▼ -4.5 pp |
| 2019 | 81.6% | Skr51.23 Million | Skr62.78 Million | Skr61.88 Million | Skr10.64 Million | ▼ -4.0 pp |
| 2018 | 85.6% | Skr36.83 Million | Skr43.01 Million | Skr47.19 Million | Skr10.36 Million | ▼ -8.6 pp |
| 2017 | 94.3% | Skr81.68 Million | Skr86.67 Million | Skr91.07 Million | Skr9.39 Million | ▼ -0.2 pp |
| 2016 | 94.5% | Skr27.65 Million | Skr29.26 Million | Skr32.95 Million | Skr5.30 Million | ▲ +33.3 pp |
| 2015 | 61.2% | Skr24.19 Million | Skr39.52 Million | Skr30.50 Million | Skr6.32 Million | ▼ -9.4 pp |
| 2014 | 70.6% | Skr31.20 Million | Skr44.16 Million | Skr37.21 Million | Skr6.02 Million | ▼ -29.5 pp |
| 2013 | 100.1% | Skr60.36 Million | Skr60.29 Million | Skr67.09 Million | Skr6.73 Million | ▲ +7.7 pp |
| 2012 | 92.5% | Skr378.67 Million | Skr409.58 Million | Skr390.05 Million | Skr11.38 Million | ▲ +2.9 pp |
| 2011 | 89.6% | Skr412.88 Million | Skr460.97 Million | Skr471.51 Million | Skr58.63 Million | ▲ +4.9 pp |
| 2010 | 84.7% | Skr266.62 Million | Skr314.78 Million | Skr521.03 Million | Skr254.41 Million | — |